Regeneron's Remarkable Resurgence: Charting the Course of a Biotech Comeback Dame Judi Dench's Vision Struggles: Understanding Macular Degeneration Lilly's Bold Bet: A Second Chance for a Troubled Gene Therapy in Retinal Disease A New Chapter for Ophthalmology: Regeneron and Sandoz Resolve Landmark Eylea Patent Battle